MM

Michael Montgomery

Description

Michael Montgomery

Investor Profile

Michael Montgomery has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Michael Montgomery frequently co-invest with?

Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Alzheimer's Drug Discovery Foundation
North America, New York, United States, New York
Co-Investments: 1
Kayne Anderson Capital Advisors
North America, California, United States, Los Angeles
Co-Investments: 1
Outcomes Fund
North America, California, United States, Los Angeles
Co-Investments: 1
W Fund
North America, Washington, United States, Seattle
Co-Investments: 1

Which angels does Michael Montgomery often collaborate with?

Shared Deals: 1

What are some of recent deals done by Michael Montgomery?

Athira Pharma

Seattle, Washington, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

BiotechnologyPharmaceuticalTherapeutics
Series BNov 2, 2017
Amount Raised: $15,200,000